Clinical trial

Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated…

NCT00328263 · Bio-K Plus International Inc., Industry · Completed

Key facts

NCT number NCT00328263
Title Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients
Official title A Double-blind, Randomized, Placebo Controlled, Multicenter Study of the Efficacy and Safety of BIO-K*+ CL-1285* in the Prevention of Antibiotic-associated Diarrhea in Adult Patients Exposed to Nosocomial Infection.
Lead sponsor Bio-K Plus International Inc., Industry
Collaborators JSS Medical Research Inc. Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Diarrhea, Clostridium Infections
Intervention type Dietary Supplement
Interventions Lactobacillus acidophilus CL1285 and Lactobacillus casei, placebo
Enrollment 472
Start date Mar 1, 2006
Primary completion Mar 1, 2007
Completion Oct 1, 2007
First posted May 19, 2006
Last update posted Aug 7, 2014
Countries Canada

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies